1. Maghsoudi A, Baneshi MR, Hassanzadeh J.
   Estimating the Size of Most-at-Risk Populations for HIV/AIDS Using the Generalized Network Scale-Up Method: A Study in Shiraz, IranIran.
   AIDS Res Hum Retroviruses 2026.
   


2. .
   Corrigendum to: "Histoplasma capsulatum Not Detected in People with HIV and Systemic Symptoms in Port-au-Prince, Haiti".
   AIDS Res Hum Retroviruses 2026.
   


3. Sossen B, Martinson N.
   "Trace-MTB" on Sputum Xpert Ultra: New Evidence for Interpretation in High-burden Settings.
   Clin Infect Dis 2026.
   


4. Visek C, Dalmat RR, Nalutaaya A, Erisa KC, et al.
   Prevalence and Predictors of Tuberculosis in Adults and Adolescents With Sputum Trace Ultra Results in 2 High-Burden Clinical Settings.
   Clin Infect Dis 2026.
   


5. Denyer RV, Tate JP, Benator DA, Lim JK, et al.
   Hepatitis B Reactivation in a US Cohort of People With Human Immunodeficiency Virus and Hepatitis B Core Antibody After Switch to Antiretroviral Therapy Without Hepatitis B Activity.
   Clin Infect Dis 2026.
   


6. Koethe JR, Lake JE, Kantor A, Smeaton L, et al.
   A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).
   Clin Infect Dis 2026.
   


7. Casado JL, Vizcarra P, Izuzquiza I, Rodriguez-Dominguez MJ, et al.
   Long-Term Serologic Outcomes Following Treatment of Syphilis in People With HIV: A Prospective Cohort Study.
   Clin Infect Dis 2026.
   


8. Landovitz RJ, Pinedo Y, Hinestrosa F, Crofoot GE, et al.
   Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.
   Clin Infect Dis 2026.
   


9. Carstens RP, Kapoor Y, Vargo RC, Bhattacharyya A, et al.
   Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults Living With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From Two Open-Label, Phase 1 St
   Clin Infect Dis 2026.
   


10. Limas JA, Raju RY, Lewis KA, Ma A, et al.
    Barriers to Initiating HIV Pre-Exposure Prophylaxis Over Time Among Youth Who are at Higher Risk of Acquiring HIV.
    J Acquir Immune Defic Syndr 2026.
    


11. Paredes JL, Matos F, Bemplidaki D, Walia H, et al.
    Detectable coronary artery score among people living with HIV with regional, study and population variations: a systematic review and meta-analysis.
    J Acquir Immune Defic Syndr 2026.
    


12. Machtinger EL, Cuca YP, Davis K, Shumway M, et al.
    Causes of Death of Women with HIV: Discordance between Interdisciplinary Primary Care Teams and Death Certificates.
    J Acquir Immune Defic Syndr 2026.
    


13. Kwara A, Martyn-Dickens C, Sly-Moore E, Enimil A, et al.
    Pharmacokinetics of Dolutegravir in Children with HIV with and without Tuberculosis Coinfection Treated According to World Health Organization Dosing Guidelines.
    J Acquir Immune Defic Syndr 2026.
    


14. Mahida K, Jagtap SR.
    Comment on "Dose Determination Trial for Evidence-Based Behavioral Counseling to Improve".
    J Acquir Immune Defic Syndr 2026.
    


15. Owor M, Baltrusaitis K, DeMarrais P, Frenkel LM, et al.
    Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations with Risk of Postnatal HIV Transmission during Breastfeeding Among Women with and without ARV Exposure.
    J Acquir Immune Defic Syndr 2026.
    


16. Dasgupta S, Tie Y, Crim SM, Espinosa C, et al.
    Geographic differences in experiences with HIV stigma among U.S. persons with diagnosed HIV.
    J Acquir Immune Defic Syndr 2026.
    


17. Pache L, Bui JK, Klouser LM, Fennessey CM, et al.
    Smac mimetic combined with eCD4-Ig reverses latency without reducing SHIV reservoirs in rhesus macaques.
    J Clin Invest 2026;136.
    


18. Barbee LA, Zhang S, Golden MR, Khosropour CM, et al.
    The Natural History of Mycoplasma genitalium at the Pharynx and Rectum in a Cohort of Men who have Sex with Men: Prevalence, Incidence, Duration and Symptomatology.
    J Infect Dis 2026.
    


19. Mani M, Clipman SJ, Bailey JR, Sterling RK, et al.
    Single-cell hepatitis B sequencing reveals distinct viral infection events consistent with superinfection.
    J Infect Dis 2026.
    


20. Matos JM, Marshall VA, Cornejo Castro EM, Miley WJ, et al.
    Kaposi sarcoma herpesvirus (KSHV) subtypes and impact on outcomes in KSHV-associated diseases.
    J Infect Dis 2026.
    


21. Saavedra-Cervera B, Nguenha D, Chihota V, Yimer G, et al.
    Dynamics of Quantiferon-Gold Plus results in a large TB preventive treatment trial across three high-burden HIV/TB countries.
    J Infect Dis 2026.
    


22. Ohkura S, Osanai H, Shimizu M, Horie M, et al.
    Study of retroviral restrictions in a Tadarida bat cell line enlightens specific early blocks and TRIM5 locus multiplication.
    J Virol 2026.
    


23. Kasujja FX, Aikaeli F, Garrib A, van Widenfelt E, et al.
    Integrated community-based versus facility-based care for people with HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-COMM): an open-label, multicountry, cluster-randomised trial.
    Lancet 2026;407:1084-1094.
    


24. Cerqueira-Silva T, Boaventura VS, Paixao ES, Sanchez M, et al.
    Long-term risk of death after tuberculosis diagnosis and treatment.
    Nat Med 2026.
    

Display articles in

• Abstract format